Global Blood Therapeutics (GBT) P/FCF US GAAP (year values) |
|||||||||
2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | CAGR 5 years ? | |||
P/FCF | -17.3 | -15.0 | -23.4 | -12.0 | -7.08 | -17.6 | |||
Changes by years, y/y, % | +149% | -14% | +56% | -49% | -41% | +0.4% |
Global Blood Therapeutics. P/FCF
Global Blood Therapeutics. P/FCF, changes, %
Global Blood Therapeutics (GBT) P/FCF US GAAP (quarter values) |
||||||||
2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | LTM ? | |||
P/FCF | -10.1 | -6.66 | -7.26 | -8.92 | -8.34 | -17.6 | ||
Changes by years, y/y, % | -35% | -54% | -40% | -22% | -17% | |||
Changes by quarters, q/q, % | -12% | -34% | +9% | +23% | -7% |